Redhill Biopharma Current Valuation vs. Market Capitalization
| RDHL Stock | USD 6.74 0.34 5.31% |
For Redhill Biopharma profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Redhill Biopharma to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Redhill Biopharma utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Redhill Biopharma's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Redhill Biopharma over time as well as its relative position and ranking within its peers.
Redhill |
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Redhill Biopharma. If investors know Redhill will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Redhill Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (302.63) | Revenue Per Share 4.733 | Quarterly Revenue Growth (0.28) | Return On Assets (0.45) | Return On Equity (17.09) |
The market value of Redhill Biopharma is measured differently than its book value, which is the value of Redhill that is recorded on the company's balance sheet. Investors also form their own opinion of Redhill Biopharma's value that differs from its market value or its book value, called intrinsic value, which is Redhill Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Redhill Biopharma's market value can be influenced by many factors that don't directly affect Redhill Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Redhill Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Redhill Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Redhill Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Redhill Biopharma Market Capitalization vs. Current Valuation Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Redhill Biopharma's current stock value. Our valuation model uses many indicators to compare Redhill Biopharma value to that of its competitors to determine the firm's financial worth. Redhill Biopharma is rated below average in current valuation category among its peers. It is rated below average in market capitalization category among its peers creating about 4.51 of Market Capitalization per Current Valuation. At this time, Redhill Biopharma's Market Cap is quite stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Redhill Biopharma by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Redhill Current Valuation vs. Competition
Redhill Biopharma is rated below average in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Health Care industry is at this time estimated at about 4.64 Billion. Redhill Biopharma adds roughly 1.91 Million in current valuation claiming only tiny portion of equities under Health Care industry.
Redhill Market Capitalization vs. Current Valuation
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Redhill Biopharma |
| = | 1.91 M |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
Redhill Biopharma |
| = | 8.63 M |
In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.
Redhill Market Capitalization vs Competition
Redhill Biopharma is rated below average in market capitalization category among its peers. Market capitalization of Health Care industry is at this time estimated at about 4.53 Billion. Redhill Biopharma adds roughly 8.63 Million in market capitalization claiming only tiny portion of equities under Health Care industry.
Redhill Biopharma Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Redhill Biopharma, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Redhill Biopharma will eventually generate negative long term returns. The profitability progress is the general direction of Redhill Biopharma's change in net profit over the period of time. It can combine multiple indicators of Redhill Biopharma, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | -399.6 K | -379.6 K | |
| Operating Income | 12.6 M | 13.3 M | |
| Income Before Tax | 24 M | 25.1 M | |
| Total Other Income Expense Net | 11.3 M | 11.9 M | |
| Net Income | 23.9 M | 25.1 M | |
| Income Tax Expense | (2.00) | (1.90) | |
| Net Income From Continuing Ops | 23.9 M | 25.1 M | |
| Net Loss | -88 M | -83.6 M | |
| Net Interest Income | -2.2 M | -2.3 M | |
| Interest Income | 94 K | 176.2 K | |
| Change To Netincome | 28.3 M | 29.7 M | |
| Net Income Per Share | 3.69 | 3.88 | |
| Income Quality | (1.50) | (1.42) | |
| Net Income Per E B T | 1.00 | 1.14 |
Redhill Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Redhill Biopharma. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Redhill Biopharma position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Redhill Biopharma's important profitability drivers and their relationship over time.
Use Redhill Biopharma in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Redhill Biopharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Redhill Biopharma will appreciate offsetting losses from the drop in the long position's value.Redhill Biopharma Pair Trading
Redhill Biopharma Pair Trading Analysis
The ability to find closely correlated positions to Redhill Biopharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Redhill Biopharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Redhill Biopharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Redhill Biopharma to buy it.
The correlation of Redhill Biopharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Redhill Biopharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Redhill Biopharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Redhill Biopharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Redhill Biopharma position
In addition to having Redhill Biopharma in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Broad Municipals ETFs Thematic Idea Now
Broad Municipals ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Broad Municipals ETFs theme has 50 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Broad Municipals ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Your Equity Center. For more information on how to buy Redhill Stock please use our How to buy in Redhill Stock guide.You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
To fully project Redhill Biopharma's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Redhill Biopharma at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Redhill Biopharma's income statement, its balance sheet, and the statement of cash flows.